Spectrum Pharmaceuticals, Inc. (SPPI) Appoints Industry Veteran, Former Amgen (AMGN) Executive Joseph Turgeon, as Senior Vice President Sales & Commercial Operations

Tools

Spectrum Pharmaceuticals, Inc. (SPPI) Appoints Industry Veteran, Former Amgen (AMGN) Executive Joseph Turgeon, as Senior Vice President Sales & Commercial Operations

10/29/2012 7:51:33 AM

HENDERSON, Nev.---Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the appointment of Joseph Turgeon as Senior Vice President Sales & Commercial Operations. Mr. Turgeon will be responsible for the commercialization and sales of all Spectrum products; currently, Spectrum markets FUSILEV® (levoleucovorin) for Injection; FOLOTYN® (pralatrexate injection); and ZEVALIN® (ibritumomab tiuxetan) Injection for intravenous use. Mr. Turgeon brings over 25 years of pharma sales experience, including various executive leadership roles at Amgen. He will report to Ken Keller, Executive Vice President and Chief Operating Officer.